TY - JOUR
T1 - Current trends in diabetes mellitus database research in Japan
AU - Kohsaka, Shun
AU - Morita, Naru
AU - Okami, Suguru
AU - Kidani, Yoko
AU - Yajima, Toshitaka
N1 - Funding Information:
The publication fee for this paper is provided by AstraZeneca K.K. and Ono Pharmaceutical Co., Ltd., Osaka, Japan.
Publisher Copyright:
© 2021 John Wiley & Sons Ltd
PY - 2021/4
Y1 - 2021/4
N2 - With the widespread use of electronic medical records and administrative claims databases, analytic results from so-called real-world data have become increasingly important in healthcare decision-making. Diabetes mellitus is a heterogeneous condition that involves a broad spectrum of patients. Real-world database studies have been recognised as a powerful tool to understand the impact of current practices on clinical courses and outcomes, such as long-term glucose control, development of microvascular or macro-vascular diseases, and mortality. Diabetes is also a major global health issue and poses a significant social and economic burden worldwide. Therefore, it is critical to understand the epidemiology, clinical course, treatment reality, and long-term outcomes of diabetes to determine realistic solutions to a variety of disease-related issues that we are facing. In the present review, we summarise the healthcare system and large-scale databases currently available in Japan, introduce the results from recent database studies involving Japanese patients with diabetes, and discuss future opportunities and challenges for the use of databases in the management of diabetes.
AB - With the widespread use of electronic medical records and administrative claims databases, analytic results from so-called real-world data have become increasingly important in healthcare decision-making. Diabetes mellitus is a heterogeneous condition that involves a broad spectrum of patients. Real-world database studies have been recognised as a powerful tool to understand the impact of current practices on clinical courses and outcomes, such as long-term glucose control, development of microvascular or macro-vascular diseases, and mortality. Diabetes is also a major global health issue and poses a significant social and economic burden worldwide. Therefore, it is critical to understand the epidemiology, clinical course, treatment reality, and long-term outcomes of diabetes to determine realistic solutions to a variety of disease-related issues that we are facing. In the present review, we summarise the healthcare system and large-scale databases currently available in Japan, introduce the results from recent database studies involving Japanese patients with diabetes, and discuss future opportunities and challenges for the use of databases in the management of diabetes.
KW - antidiabetic drug
KW - cardiovascular disease
KW - complications
KW - database research
KW - diabetes
KW - pharmaco-epidemiology
UR - http://www.scopus.com/inward/record.url?scp=85104057639&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104057639&partnerID=8YFLogxK
U2 - 10.1111/dom.14325
DO - 10.1111/dom.14325
M3 - Review article
C2 - 33835639
AN - SCOPUS:85104057639
SN - 1462-8902
VL - 23
SP - 3
EP - 18
JO - Diabetes, Obesity and Metabolism
JF - Diabetes, Obesity and Metabolism
IS - S2
ER -